Edition:
United Kingdom

People: Cerus Corp (CERS.OQ)

CERS.OQ on NASDAQ Stock Exchange Global Market

5.61USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$5.61
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
265,727
52-wk High
$8.05
52-wk Low
$4.49

Swisher, Daniel 

Mr. Daniel N. Swisher, Jr., is an Independent Chairman of the Board of Cerus Corporation. Mr. Swisher has served as a member of our Board since June 2011 and has served as Chair of the Board since October 2013. Mr. Swisher has served as the President and Chief Operating Officer of Jazz Pharmaceuticals plc since January 2018. Prior to that, he served as the Chief Executive Officer of Sunesis Pharmaceuticals, Inc., or Sunesis, and a member of its board of directors from January 2004 through December 2017, and as its President since August 2005. From December 2001 to December 2003, he served as the Chief Business Officer and Chief Financial Officer of Sunesis. From June 1992 to September 2001, Mr. Swisher served in various management roles, including Senior Vice President of Sales and Marketing, for ALZA Corporation. He also serves on the board of directors of Corcept Therapeutics Incorporated, or Corcept Therapeutics, a pharmaceutical company. Mr. Swisher holds a B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business.

Basic Compensation

Total Annual Compensation, USD 80,250
Restricted Stock Award, USD 86,372
Long-Term Incentive Plans, USD --
All Other, USD 86,374
Fiscal Year Total, USD 252,996

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Daniel Swisher

252,996

William Greenman

2,983,440

Kevin Green

1,022,270

Carol Moore

981,744

William Moore

--

Laurence Corash

1,040,260
As Of  31 Dec 2018